Rosebud Biosciences
YC W22San Francisco, US · Founded 2020 · 3 employees · 1 known investors
Rosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.
Also known as Rosebud Biosciences Inc.
BiotechDeep TechHealthtechMedical DevicesAI-powered Drug DiscoveryPediatricsUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W22)
Rosebud Biosciences was founded in 2020 by Kitch Wilson and Evan Lyall.
KW
Kitch Wilsonin𝕏Co-founder and CEOKitch Wilson is a physician and molecular biologist with over 15 years of experience in induced pluripotent stem cell research and genomic technologies. He completed medical and doctoral training at Stanford, where he spent six years as an attending physician before co-founding Rosebud Biosciences.
EL
Evan Lyallin𝕏Co-founder and CTOHe holds a PhD and has spent a decade in advanced microscopy, machine learning, and data engineering, including research at UC Berkeley on neural coding and brain-machine interfaces, followed by contract data and ML engineering roles at early-stage companies.
Investors · 1
The YC application· Winter 2022 batch
What they told YC
- How long have each of you been working on this? How much of that has been full-time? Please explain.
- Kitch, the CEO, started working full-time on the company's business plan and platform concept in June 2020, and Evan joined full-time as cofounder and CTO in January 2021.
Summarized from the founders' answers on their Y Combinator profile.
In the news
Frequently asked questions
- What does Rosebud Biosciences do?
- Rosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.
- Who founded Rosebud Biosciences?
- Rosebud Biosciences was founded by Kitch Wilson, Evan Lyall in 2020.
- Who are Rosebud Biosciences's investors?
- Rosebud Biosciences's investors include Y Combinator.
- Where is Rosebud Biosciences headquartered?
- Rosebud Biosciences is headquartered in San Francisco, US.